There are 2789 resources available
51P - Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
52P - Assessment of futibatinib exposure–response (E–R) relationships in patients with advanced solid tumors, including cholangiocarcinoma (CCA)
Presenter: Antoine Hollebecque
Session: ePoster Display
53P - FGFR2 fusion and/or rearrangement profiling in Chinese patients with intrahepatic cholangiocarcinoma
Presenter: Xiao-Wu Huang
Session: ePoster Display
54P - Assessment of EU4 laboratory readiness for FGFR2 fusion testing of cholangiocarcinoma by NGS
Presenter: Marianna Sciortino
Session: ePoster Display
95P - Optimizing selection of experimental treatment for patients with advanced cancer using whole genome sequencing
Presenter: Melinda Pruis
Session: ePoster Display
96P - Real-world single institution clinical outcome study of the impact of comprehensive genomic profiling (CGP) on targeted therapy selection and cancer patient survival
Presenter: Bhaskara Reddy Madhira
Session: ePoster Display
97P - Comparative serum metabolome analysis as a diagnostic tool in concomitant rheumatic and malignant diseases
Presenter: Dorothea Marx
Session: ePoster Display
98P - A stable NGS method to detect microsatellite instability status across different batches, sequencing platforms and cancer types
Presenter: Chenghong Lin
Session: ePoster Display
99P - The differentially fragmented regions in cell-free DNA of colorectal cancer patients
Presenter: Dmitry Shcherbo
Session: ePoster Display